The most Important Science of the decades is here and curing diseases and enhances longevity. Introducing CAR-NK Cells expressing PD-L1. The most Important and Useful Cells in our bodies to fight ALL types of Cancers and Infections. BioShield

After every ticker spammer on $IBRX , it’s time for me to step up Nobody actually knows what this approval means. This data was normally expected to come out on January 6 (bladder cancer was already approved, this is just another tumor), but FDA decided to reveal their decision 2.5 months ahead. As it can be understood both by the side of FDA and Dr. Patrick Soon’s interviews/lectures, the platform is superior. The easiest way to understand the advanced capabilities is that White House officials even try to poach Anktiva for their close relatives. Now the stage is set to reveal the next readouts which is QUILT-2005. This is also another bladder cancer pipeline but for “BCG-naive” patients. Dr. Patrick Soon says that Anktiva works totally better in “BCG-naive” patients. If FDA approved BCG-unresponsive 2.5 months in advance, how do you think FDA will decide for QUILT-2005? QUILT-2005 readouts will come out also in Q4. What’s good is that this is phase 2b so that means they could immediately file sBLA without taking the pipeline through phase 3 as there’s an already approved bladder cancer pipeline. Q4 might continue to be strong

I am not asking people to add @IBRX shares on red day. I just do it myself :)

ImmunityBio is excited to attend the European Society for Medical Oncology (ESMO) 2026 Congress in Madrid - a highly influential global oncology meeting bringing together clinicians, researchers, patient advocates, and industry leaders from around the world. #ESMO26 will be a platform for advances in oncology research, clinical practice, and patient care. We look forward to engaging with the global oncology community, exploring impactful new data, and contributing to the future of cancer care on a global scale. @myESMO

The Coalition of Unelected

Support for my claim - 2028 and 2030 year end revenues at 1.4b and 3.1b respectively. Discount those back and you get a P/S of 3x . Future my good doctor, not present. Future is what we use to dcf

NEW STUDY: Enoki Mushroom SHUTS DOWN Cancer Growth by 99.8% in Animal Models Just 10 days of oral treatment virtually HALTED tumor growth, with tumors COMPLETELY DISAPPEARING in 67% of mice. This is a common EDIBLE MUSHROOM sold in grocery stores...

Lock in, folks. It’s flu season. Everyone should have Ivermectin and Chlorine Dioxide to protect themselves and their families Stay away from the new mRNA flu jab! And stay away from those taking flu and COVID jabs - they are going to be making everyone sick!! 🤒

$IBRX bullish momentum is building as ANKTIVA + BCG delivers promising bladder cancer trial results compared with historical Keytruda data! @grok, could this be a major breakout catalyst?

$IBRX short from rumble rumble.com/shorts/v7gzg20 Share it pls

Gods

Why is twitter not letting me boost my tweet that I think ALS is an immunological disease?

$IBRX The genius of Dr Soon-Shiong. Not many small biotechs go out the gate with Approval in 34 Countries. 7 of Top 10 markets already approved! Japan, Turkey Soon!

Anktiva for lung cancer can't be denied. The puppets at @FDADrugs will be hated by big pharmas for approving Anktiva for more indications in the US, but they can't do anything. Good hearts win @ImmunityBio @DrPatrick

Meanwhile, if you can't have access to Anktiva because the fucking @FDADrugs limit its use for other types of cancers. You can go to Russia or old Soviet countries to buy Roncoleukin to treat yourself. Intermittment lowdoses are safe and effective. Here biotech.spb.ru/mehanizm-dejs…

@DrPatrick you called it "an important step." It is. But it was never your first. A journey of a thousand miles begins with a single step. Everyone knows the line. Almost no one has walked the distance. Your first step was more than twenty years ago, back when teaching the body's own cells to hunt cancer sounded like a fantasy. This approval is closer to your seven thousandth. One for every day you spent refusing to quit on the people waiting for it. And it is still just one more step toward the only place you have ever been walking: a world where cancer is something we cure, not something we fear. Keep going, Doctor. The whole world is walking behind you.

Thank you to @FDADrugs for making ANKTIVA accessible to all patients in non muscle invasive bladder cancer who failed BCG therapy. @ImmunityBio - The first treatment approved for this group of patients. An important step for cancer immunotherapy 2.0.